The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms.

The aim of this study was to investigate the association between Cystic Fibrosis (CF) and affective temperaments, considering the relevance of ionic balances in neural excitability, as a possible neurobiological basis for temperamental expression. A cross-sectional study involving 55 adult CF patients was conducted. Sociodemographic, clinical and therapeutic characteristics, temperamental and personality dispositions and depressive and anxiety symptoms were evaluated through standardized semi-structured and structured interviews. The majority of the enrolled CF patients were receiving Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy (72.7%), and most of them had hyperthymic temperament predominance (29.1%). Different TEMPS-A (Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire) dimensions were not associated with the type of CF phenotype-related mutation or with the use of CFTR-modulator therapy. However, a tendency towards irritability was noted in patients not undergoing CFTR modulator therapy (6.7 ± 4.72 vs. 4.7 ± 4.33; p = 0.13). In light of the limitations imposed by the cross-sectional nature of the study, a hyperthymic temperament was found to be protective against current or lifetime psychopathologic events, whereas the other temperaments were associated with positive psychopathological anamnesis. Based on the measurement of temperament profiles and the study of their associations with clinically relevant variables, we argue that subjecting CF patients to such a temperament assessment could prove beneficial in the transition towards integrated and personalized care.

Linguistic profile automated characterisation in pluripotential clinical high-risk mental state (CHARMS) conditions: methodology of a multicentre observational study.

INTRODUCTION: Language is usually considered the social vehicle of thought in intersubjective communications. However, the relationship between language and high-order cognition seems to evade this canonical and unidirectional description (ie, the notion of language as a simple means of thought communication). In recent years, clinical high at-risk mental state (CHARMS) criteria (evolved from the Ultra-High-Risk paradigm) and the introduction of the Clinical Staging system have been proposed to address the dynamicity of early psychopathology. At the same time, natural language processing (NLP) techniques have greatly evolved and have been successfully applied to investigate different neuropsychiatric conditions. The combination of at-risk mental state paradigm, clinical staging system and automated NLP methods, the latter applied on spoken language transcripts, could represent a useful and convenient approach to the problem of early psychopathological distress within a transdiagnostic risk paradigm. METHODS AND ANALYSIS: Help-seeking young people presenting psychological distress (CHARMS+/- and Clinical Stage 1a or 1b; target sample size for both groups n=90) will be assessed through several psychometric tools and multiple speech analyses during an observational period of 1-year, in the context of an Italian multicentric study. Subjects will be enrolled in different contexts: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa-IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Mental Health Department-territorial mental services (ASL 3-Genoa), Genoa, Italy; and Mental Health Department-territorial mental services (AUSL-Piacenza), Piacenza, Italy. The conversion rate to full-blown psychopathology (CS 2) will be evaluated over 2 years of clinical observation, to further confirm the predictive and discriminative value of CHARMS criteria and to verify the possibility of enriching them with several linguistic features, derived from a fine-grained automated linguistic analysis of speech. ETHICS AND DISSEMINATION: The methodology described in this study adheres to ethical principles as formulated in the Declaration of Helsinki and is compatible with International Conference on Harmonization (ICH)-good clinical practice. The research protocol was reviewed and approved by two different ethics committees (CER Liguria approval code: 591/2020-id.10993; Comitato Etico dell'Area Vasta Emilia Nord approval code: 2022/0071963). Participants will provide their written informed consent prior to study enrolment and parental consent will be needed in the case of participants aged less than 18 years old. Experimental results will be carefully shared through publication in peer-reviewed journals, to ensure proper data reproducibility. TRIAL REGISTRATION NUMBER: DOI:10.17605/OSF.IO/BQZTN.

Pentamethylcyclopentadienyl osmium complexes that contain diazoalkane, dioxygen and allenylidene ligands: preparation and reactivity.

Diazoalkane complexes [Os(η5-C5Me5)(N2CAr1Ar2)(PPh3){P(OR)3}]BPh4 (1, 2) [R = Me (1), Et (2); Ar1 = Ar2 = Ph (a); Ar1 = Ph, Ar2 = p-tolyl (b); Ar1Ar2 = C12H8 (fluorenyl) (c)] were prepared by reacting bromo-compounds OsBr(η5-C5Me5)(PPh3){P(OR)3} with an excess of diazoalkane in ethanol. The treatment of diazoalkane complexes 1 and 2 with acetylene under mild conditions (1 atm, RT) led to dipolar (3 + 2) cycloaddition affording 3H-pyrazole derivatives [Os(η5-C5Me5)(η1-[upper bond 1 start]N[double bond, length as m-dash]NC(C12H8)CH[double bond, length as m-dash]C[upper bond 1 end]H)(PPh3){P(OR)3}]BPh4 (6, 7) [R = Me (6), Et (7)] whereas reactions with terminal alkynes R1C[triple bond, length as m-dash]CH (R1 = Ph, p-tolyl, COOMe) gave vinylidene derivatives [Os(η5-C5Me5){[double bond, length as m-dash]C[double bond, length as m-dash]C(H)R1}(PPh3){P(OR)3}]BPh4 (8b-d, 9b-d) [R = Me (8), Et (9); R1 = Ph (b), p-tolyl (c), COOMe (d)]. Exposure to air of dichloromethane solutions of complexes 1 and 2 produced dioxygen derivatives [Os(η5-C5Me5)(η2-O2)(PPh3){P(OR)3}]BPh4 (10, 11) [R = Me (10), Et (11)]. Allenylidene [Os][double bond, length as m-dash]C[double bond, length as m-dash]C[double bond, length as m-dash]CR1R2 (12-14) [R1 = R2 = Ph (12, 13); R1 = Ph, R2 = Me (14)], vinylvinylidene [Os][double bond, length as m-dash]C[double bond, length as m-dash]C(H)C(Ph)[double bond, length as m-dash]CH2 (15) and 3-hydroxyvinylidene [Os][double bond, length as m-dash]C[double bond, length as m-dash]C(H)C(H)R2(OH) (16, 17) [R2 = Ph (16), H (17)] derivatives were also prepared. The vinylidene complex [Os(η5-C5Me5)([double bond, length as m-dash]C[double bond, length as m-dash]CH2)(PPh3){P(OMe)3}]BPh4 (8a) reacted with PPh3 to afford the alkenylphosphonium derivative [Os(η5-C5Me5){η1-C(H)[double bond, length as m-dash]C(H)PPh3}(PPh3){P(OMe)3}]BPh4 (18) whereas vinylidene complexes 8 and 9 reacted with water leading to the hydrolysis of the alkyne and the formation of carbonyl complexes [Os(η5-C5Me5)(CO)(PPh3){P(OR)3}]BPh4 (19, 20). The complexes were characterised by spectroscopic data (IR and NMR) and by X-ray crystal structure determination of [Os(η5-C5Me5){[double bond, length as m-dash]C[double bond, length as m-dash]C(H)p-tolyl}(PPh3){P(OEt)3}]BPh4 (9c), [Os(η5-C5Me5)(η2-O2)(PPh3){P(OMe)3}]BPh4 (10) and [Os(η5-C5Me5)(CO)(PPh3){P(OMe)3}]BPh4 (19).

Preparation and reactivity of half-sandwich organic azide complexes of osmium.

Organic azide complexes [Os(η5-C5H5)(κ1-N3R)(PPh3){P(OR1)3}]BPh4 (1, 2) [R = CH2C6H5 (a), CH2C6H4-4-CH3 (b), CH(CH3)C6H5 (c), C6H5 (d); R1 = Me (1), Et (2)] were prepared by allowing bromo-compounds [OsBr(η5-C5H5)(PPh3){P(OR1)3}] to react first with AgOTf and then with an excess of azide in toluene. Benzylazide complexes reacted in solution leading to imine derivatives [Os(η5-C5H5){κ1-NH[double bond, length as m-dash]C(R2)Ar}(PPh3){P(OR1)3}]BPh4 (3, 4) [R2 = H (a, b), CH3 (c); Ar = C6H5, C6H4-4-CH3; R1 = Me (3), Et (4)]. Phenylazide, on the other hand, reacted in solution affording the dinuclear dinitrogen complex [{Os(η5-C5H5)(PPh3)[P(OMe)3]}2(µ-N2)](BPh4)2 (5). Depending on the nature of the R substituent, the reaction of the p-cymene complex [OsCl2(η6-p-cymene)(PPh3){P(OEt)3}] with RN3 yielded imine [OsCl(η6-p-cymene){κ1-NH[double bond, length as m-dash]C(H)Ar}{P(OEt)3}]BPh4 (6) (Ar = C6H4-4-CH3) and amine derivatives [OsCl(η6-p-cymene)(κ1-NH2C6H5){P(OEt)3}]BPh4 (7). The complexes were characterised spectroscopically (IR, 1H, 31P, 15N NMR) and by the X-ray crystal structure determination of [{Os(η5-C5H5)(PPh3)[P(OMe)3]}2(µ-N2)](BPh4)2 (5).